Cabergoline for Cushing's disease: A case report
Pascual-Corrales E (1), Tomás Velázquez A (1), Zubieta JL (2), Salvador J (3), Galofré JC (4).
Cushing’s syndrome results from a prolonged exposure to excessive concentrations of free circulating glucocorticoids. ACTH dependent Cushing’s syndrome or Cushing’s disease (CD) represents approximately 80---85% of the total cases, and around 80% of them correspond to ACTH secreting pituitary adenomas.
Transesphenoidal surgery remains the first line of treatment for CD.1 Other therapeutic approaches such as medical treatment, pituitary radiotherapy or bilateral adrenalectomy constitute the second-line treatment, and are normally indicated in case of surgical failure.
CITA DEL ARTÍCULO Endocrinol Nutr. 2015 Dec;62(10):516-8. doi: 10.1016/j.endonu.2015.07.002